Respiratory Trials·org

COPD · Long-term oxygen therapy

REDOX

Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe Hypoxemia

REDOX trial design and results
Design Registry-based randomised non-superiority trial
Treatment Long-term oxygen therapy for 24 hours per day
Control Long-term oxygen therapy for 15 hours per day
Population 241 patients with severe hypoxaemia
Follow-up 1 year
Primary endpoint Hospitalisation or death within one year
Result Median reported use was 24.0 hours versus 15.0 hours per day. Event rates were 124.7 and 124.5 per 100 person-years (HR 0.99, 95% CI 0.72 to 1.36; p=0.007 for nonsuperiority). No substantial differences in all-cause hospitalisation, death, or adverse events. No patient was lost to follow-up.

Among patients with severe hypoxemia, long-term oxygen therapy used for 24 hours per day did not result in a lower risk of hospitalization or death within 1 year than therapy for 15 hours per day.

The trial authors, in the published abstract

How it has aged

Directly tests the assumption inherited from NOTT that more oxygen is better, and finds it wanting. Fifteen hours is enough, which matters a great deal to patients tethered to a concentrator.

Publications

Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe Hypoxemia

Ekström M, Andersson A, Papadopoulos S, et al. Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe Hypoxemia. N Engl J Med 2024 Sep 19;391(11):977-988.

  • Identical rates of hospitalisation or death at 24 versus 15 hours per day
  • No difference in adverse events